News

BART is currently funding a large clinical trial on reducing blood loss in hip and knee replacement patients entitled TRAC-24. The TRAC -24 Research Nurses are Una Martin and Leeann Bryce.

Thanks to everyone who has signed up for the BART Walk.  Look forward to seeing you all on Sunday 12th June.

Our latest paper has been published in the March edition of the Bone and Joint Journal. The paper title is ‘Aspirin for thromboprophylaxis after primary lower limb arthroplasty: early thromboembolic events and 90 day mortality in 11 459 patients’ and the main author is Mr Luke Ogonda, a consultant orthopaedic surgeon in lower limb arthroplasty and a past BART fellow in 2004/05.

This paper looks the incidence of patient clots (pulmonary embolism or deep vein thrombosis) and mortality following hip and knee replacements in the Primary Joint Unit at Musgrave Park Hospital from 2002 to 2014.

You can view this publication at http://www.ncbi.nlm.nih.gov/pubmed/26920959

The British Hip Society annual scientific meeting was held in Norwich from the 16th to 18th of March and was attended by various members of the Primary Joint Unit at Musgrave Park Hospital who were presenting both oral and poster presentations. We are delighted to announce that Mr Chris O’Neill won the McKee prize for best oral / podium presentation. His paper title was 'A Randomised Controlled Study Investigating the Effect of Patient Pelvic Positioning on Radiological Acetabular Inclination during Total Hip Arthroplasty.'

Chris is a trainee orthopaedic surgeon and this work was completed as part of his MD when he was a BART fellow within the Primary Joint Unit from 2012 to 2013. The MD was funded by BART. The masters was carried out in conjunction with the School of medicine, Dentistry and Biomedical sciences at the Queen’s University of Belfast.

Well done Chris!

BART is currently funding a large clinical trial on reducing blood loss in hip and knee replacement patients (TRAC-24). The title of the study is a ‘single centre randomised controlled trial to assess the effect of the addition of twenty-four hours of oral tranexamic acid post-operatively to a single intra-operative intravenous dose of tranexamic acid on calculated blood loss following primary hip and knee arthroplasty’. During an operation it is not unusual for a patient to lose almost a third of the total blood in their body with an average blood loss of approximately 1.3 Litres. A drug called tranexamic acid is regularly used in other areas of medicine to reduce blood loss. As well as having a direct beneficial effect on the patient as less blood is lost, it also significantly reduces the requirement for blood transfusions (a major issue for the NHS). This study will give patients tranexamic acid after their operation which is when we feel that the most blood is lost.

The study will cost over £500,000 and is the largest study of its kind so far in the world and we are hoping that the results will greatly improve the care of both our patients and patients internationally. We have been planning this study for over two years and are delighted that recruitment will finally start this year in April. Once our ethics and governance approvals are through we will be able to start. We have recently recruited two research nurses to help us with this study. All your generous donations to BART have enabled this study to happen!

Our research would not be possible without the important donations we receive throughout the year. So please help us further our work by sending a donation today.

Address Details

BART
Outcomes Assessment Unit
Musgrave Park Hospital
Stockman’s Lane
BELFAST BT9 7JB

Contact Details

Tel: 028 9068 3530

Fax: 028 9068 3530

Email: click here to email us